{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,31]],"date-time":"2024-07-31T08:24:25Z","timestamp":1722414265724},"reference-count":17,"publisher":"Spandidos Publications","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp Ther Med"],"DOI":"10.3892\/etm.2019.7325","type":"journal-article","created":{"date-parts":[[2019,2,27]],"date-time":"2019-02-27T08:41:32Z","timestamp":1551256892000},"source":"Crossref","is-referenced-by-count":3,"title":["Cyclosporin population pharmacokinetics in pediatric refractory nephrotic syndrome based on real\u2011world studies: Effects of body weight and spirolactone administration"],"prefix":"10.3892","author":[{"given":"Dongdong","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Pharmacy, Children's Hospital of Fudan University, Shanghai 201102, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, People's Hospital of Jiangyin, Jiangyin, Jiangsu 214400, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiping","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Children's Hospital of Fudan University, Shanghai 201102, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2019,2,27]]},"reference":[{"key":"key20200713120503_b1-etm-0-0-7325","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S0140-6736(03)14184-0","article-title":"Nephrotic syndrome in childhood","volume":"362","author":"Eddy","year":"2003","journal-title":"Lancet"},{"key":"key20200713120503_b2-etm-0-0-7325","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1007\/s004670100021","article-title":"Time trends and ethnic patterns of childhood nephrotic syndrome in Yorkshire, UK","volume":"16","author":"McKinney","year":"2001","journal-title":"Pediatr Nephrol"},{"key":"key20200713120503_b3-etm-0-0-7325","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1136\/adc.57.7.544","article-title":"Long-term outcome of primary nephrotic syndrome","volume":"57","author":"Koskimies","year":"1982","journal-title":"Arch Dis Child"},{"key":"key20200713120503_b4-etm-0-0-7325","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/s00467-012-2310-x","article-title":"Improving Global Outcomes: Treatment of steroid-sensitive nephrotic syndrome: New guidelines from KDIGO","volume":"28","author":"Lombel","year":"2013","journal-title":"Pediatr Nephrol"},{"key":"key20200713120503_b5-etm-0-0-7325","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1681\/ASN.V85769","article-title":"Prognostic significance of the early course of minimal change nephrotic syndrome: Report of the international study of kidney disease in children","volume":"8","author":"Tarshish","year":"1997","journal-title":"J Am Soc Nephrol"},{"key":"key20200713120503_b6-etm-0-0-7325","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1159\/000101367","article-title":"Corticosteroids and ciclosporin A in idiopathic membranous nephropathy: Higher remission rates of nephrotic syndrome and less adverse reactions than after traditional treatment with cytotoxic drugs","volume":"27","author":"Goumenos","year":"2007","journal-title":"Am J Nephrol"},{"key":"key20200713120503_b7-etm-0-0-7325","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1007\/BF00869823","article-title":"Ciclosporin treatment in children with steroid-dependent nephrotic syndrome","volume":"4","author":"Kitano","year":"1990","journal-title":"Pediatr Nephrol"},{"key":"key20200713120503_b8-etm-0-0-7325","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/BF00853209","article-title":"Long-term ciclosporin treatment in children with steroid-dependent nephrotic syndrome","volume":"7","author":"Tanaka","year":"1993","journal-title":"Pediatr Nephrol"},{"key":"key20200713120503_b9-etm-0-0-7325","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1038\/aps.2013.9","article-title":"Population pharmacokinetics of ciclosporin in Chinese children with aplastic anemia: Effects of weight, renal function and stanozolol administration","volume":"34","author":"Ni","year":"2013","journal-title":"Acta Pharmacol Sin"},{"key":"key20200713120503_b10-etm-0-0-7325","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1111\/jcpt.12396","article-title":"Population pharmacokinetics of tacrolimus in Thai kidney transplant patients: Comparison with similar data from other populations","volume":"41","author":"Vadcharavivad","year":"2016","journal-title":"J Clin Pharm Ther"},{"key":"key20200713120503_b11-etm-0-0-7325","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s40262-013-0037-x","article-title":"Ciclosporin population pharmacokinetics and Bayesian estimation in thoracic transplant recipients","volume":"52","author":"Fruit","year":"2013","journal-title":"Clin Pharmacokinet"},{"key":"key20200713120503_b12-etm-0-0-7325","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1111\/j.1365-2125.2011.04116.x","article-title":"Population pharmacokinetics of ciclosporin in haematopoietic allogeneic stem cell transplantation with emphasis on limited sampling strategy","volume":"73","author":"Wilhelm","year":"2012","journal-title":"Br J Clin Pharmacol"},{"key":"key20200713120503_b13-etm-0-0-7325","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1111\/jcpt.12707","article-title":"Population pharmacokinetics of tacrolimus in paediatric systemic lupus erythematosus based on real-world study","volume":"43","author":"Wang","year":"2018","journal-title":"J Clin Pharm Ther"},{"key":"key20200713120503_b14-etm-0-0-7325","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1007\/s00228-018-2454-0","article-title":"Population pharmacokinetics of vancomycin and AUC-guided dosing in Chinese neonates and young infants","volume":"74","author":"Chen","year":"2018","journal-title":"Eur J Clin Pharmacol"},{"key":"key20200713120503_b15-etm-0-0-7325","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1146\/annurev.pharmtox.48.113006.094708","article-title":"Mechanism-based concepts of size and maturity in pharmacokinetics","volume":"48","author":"Anderson","year":"2008","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"key20200713120503_b16-etm-0-0-7325","first-page":"CD001533","article-title":"Corticosteroid therapy for nephrotic syndrome in children","author":"Hahn","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"key20200713120503_b17-etm-0-0-7325","doi-asserted-by":"publisher","first-page":"10","DOI":"10.2165\/00003088-199223010-00002","article-title":"Pharmacokinetic studies in paediatric patients. Clinical and ethical considerations","volume":"23","author":"Kauffman","year":"1992","journal-title":"Clin Pharmacokinet"}],"container-title":["Experimental and Therapeutic Medicine"],"original-title":[],"deposited":{"date-parts":[[2022,9,12]],"date-time":"2022-09-12T18:07:20Z","timestamp":1663006040000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/etm.2019.7325"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,27]]},"references-count":17,"URL":"https:\/\/doi.org\/10.3892\/etm.2019.7325","relation":{},"ISSN":["1792-0981","1792-1015"],"issn-type":[{"value":"1792-0981","type":"print"},{"value":"1792-1015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,27]]}}}